DUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.
Cameron,
Actual DUPIXENT patient.
Individual results may vary.
Before
Treatment
AFTER TREATMENT
With
DUPIXENT at
16 Weeks
Actual 4-year-old clinical trial patient treated with DUPIXENT and a topical corticosteroid. This patient met clinical trial criteria for clear or almost clear skin. Individual results may vary.
Results from a clinical trial of patients ages 6 months to 5 years with moderate-to-severe eczema at 16 weeks:
28% on DUPIXENT + TCS
vs 4% on TCS only
48% on DUPIXENT + TCS
vs 9% on TCS only
53% on DUPIXENT + TCS vs 11% on TCS only
TCS, topical corticosteroids.
Long-term safety results in young children continuing on DUPIXENT with or without TCS in the pediatric extension study through 1 year were consistent with the adult clinical trials. In addition, hand-foot-and-mouth disease and warts were reported. In these reported cases, patients continued treatment with DUPIXENT.
Most common side effects include:
View the possible side effects of DUPIXENT
What you should know about the patients in this study:
Great! Sign up for DUPIXENT MyWay®, our patient support program, to access program benefits and get one-on-one support every step of the way, including help with filling your first prescription.
If you’re still struggling with moderate-to-severe eczema, maybe it’s time to change the conversation.
Answer a few short questions about your eczema symptoms and treatment goals. We’ll turn it into a personalized guide you can use at your next visit.
Specialists like dermatologists or allergists often have more experience treating moderate-to-severe eczema and can help create a personalized care plan for you.
Feel like you're struggling with your symptoms?
Sign up for information that can help.
